Erratum: Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways (Scientific Reports (2016) 6 (23034) DOI: 10.1038/srep23034);Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kral, Julia Barbara ^a   Kuttke, Mario ^a   Schrottmaier, Waltraud Cornelia ^a   Birnecker, Birgit ^a   Warszawska, Joanna ^a,b   Wernig, Christina ^a   Paar, Hannah ^a   Salzmann, Manuel ^a   Sahin, Emine ^a   Brunner, Julia Stefanie ^a   Österreicher, Christoph ^a   Knapp, Sylvia ^a,b   Assinger, Alice ^a   Schabbauer, Gernot ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BLEOMYCIN; COLLAGEN; CYTOKINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN LYSINE 6 OXIDASE; PTEN PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BONE MARROW CELL; C57BL MOUSE; CHEMICALLY INDUCED; CLASSIFICATION; DEFICIENCY; ENZYME ACTIVATION; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLEOMYCIN; BLOTTING, WESTERN; COLLAGEN; CYTOKINES; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-LYSINE 6-OXIDASE; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84961827089     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26048     Document Type: Erratum

References (54)

1. Wilson, M. S., Wynn, T. A. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal. Immunol. 2, 103-121 (2009).
2. Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210 (2008).
3. Wynn, T. A., Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040 (2012).
4. Border, W. A., Noble, N. A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292 (1994).
5. Zhang, Y. et al. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling. Mol. Ther. 22, 974-985 (2014).
6. Minagawa, S. et al. Selective targeting of TGF-beta activation to treat fibroinflammatory airway disease. Sci. Transl. Med. 6, 241-79 (2014).
7. Zhu, Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest 103, 779-788 (1999).
8. Chiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., Wynn, T. A. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34, 273-282 (2001).
9. Murray, L. A. et al. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am. J. Respir. Cell Mol. Biol. 50, 985-994 (2014).
10. Desallais, L. et al. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Res. Ther. 16, R157 (2014).
11. Takizawa, H. et al. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters. Clin. Exp. Immunol. 107, 175-181 (1997).
12. O'Reilly, S., Ciechomska, M., Cant, R., van Laar, J. M. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 289, 9952-9960 (2014).
13. Luyendyk, J. P. et al. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180, 4218-4226 (2008).
14. Gunzl, P., Schabbauer, G. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties. Immunobiology 213, 759-765 (2008).
15. Sahin, E. et al. Macrophage PTEN Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses. J. Immunol. 193, 1717-1727 (2014).
16. Sahin, E. et al. Loss of Phosphatase and Tensin Homolog in APCs Impedes Th17-Mediated Autoimmune Encephalomyelitis. J. Immunol. 195, 2560-2570 (2015).
17. Schabbauer, G. et al. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J. Immunol. 185, 468-476 (2010).
18. Gunzl, P. et al. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 88, 1259-1269 (2010).
19. Yue, S. et al. Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. J. Immunol. 192, 5343-5353 (2014).
20. Moore, B. B., Hogaboam, C. M. Murine models of pulmonary fibrosis. Am. J. Physiol Lung Cell Mol. Physiol 294, L152-L160 (2008).
21. Hay, J., Shahzeidi, S., Laurent, G. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65, 81-94 (1991).
22. Gorres, K. L., Raines, R. T. Prolyl 4-hydroxylase. Crit Rev. Biochem. Mol. Biol. 45, 106-124 (2010).
23. Verrecchia, F., Chu, M. L., Mauviel, A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 276, 17058-17062 (2001).
24. Ricard-Blum, S. The collagen family. Cold Spring Harb. Perspect. Biol. 3, a004978 (2011).
25. Arranz, A. et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl. Acad. Sci. USA 109, 9517-9522 (2012).
26. Louafi, F., Martinez-Nunez, R. T., Sanchez-Elsner, T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J. Biol. Chem. 285, 41328-41336 (2010).
27. Moon, H. J., Finney, J., Ronnebaum, T., Mure, M. Human lysyl oxidase-like 2. Bioorg. Chem. 57, 231-241 (2014).
28. Kzhyshkowska, J., Gratchev, A., Goerdt, S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell Mol. Med. 10, 635-649 (2006).
29. Nair, M. G. et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect. Immun. 73, 385-394 (2005).
30. Nio, J. et al. Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry. Histochem. Cell Biol. 121, 473-482 (2004).
31. Maarsingh, H., Pera, T., Meurs, H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch. Pharmacol. 378, 171-184 (2008).
32. Murray, P. J., Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
33. van, d. V., Arvey, A., Rudensky, A. Transcriptional control of regulatory T-cell differentiation. Cold Spring Harb. Symp. Quant. Biol. 78, 215-222 (2013).
34. Lazarevic, V., Glimcher, L. H., Lord, G. M. T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 13, 777-789 (2013).
35. Basu, R., Hatton, R. D., Weaver, C. T. The Th17 family: flexibility follows function. Immunol. Rev. 252, 89-103 (2013).
36. Diaz, J. A. et al. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am. J. Transplant. 9, 1773-1783 (2009).
37. Barbarin, V., Xing, Z., Delos, M., Lison, D., Huaux, F. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am. J. Physiol Lung Cell Mol. Physiol 288, L841-L848 (2005).
38. Kitani, A. et al. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 198, 1179-1188 (2003).
39. Heit, B. et al. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat. Immunol. 9, 743-752 (2008).
40. Russo, R. C. et al. Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J. Leukoc. Biol. 89, 269-282 (2011).
41. Natsume, M. et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J. Leukoc. Biol. 66, 601-608 (1999).
42. Piguet, P. F., Grau, G. E., Collart, M. A., Vassalli, P., Kapanci, Y. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Lab Invest 61, 37-45 (1989).
43. Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest 115, 56-65 (2005).
44. Prasse, A. et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit Care Med. 173, 781-792 (2006).
45. Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit Care Med. 184, 569-581 (2011).
46. Byrne, A. J., Mathie, S. A., Gregory, L. G., Lloyd, C. M. Pulmonary macrophages: key players in the innate defence of the airways. Thorax 70, 1189-1196 (2015).
47. Liu, T. et al. The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis. PLoS. One. 9, e88362 (2014).
48. Oldroyd, S. D., Thomas, G. L., Gabbiani, G., El Nahas, A. M. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 56, 2116-2127 (1999).
49. Kitani, A. et al. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 198, 1179-1188 (2003).
50. Estes, J. D. et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J. Infect. Dis. 195, 551-561 (2007).
51. Liu, F. et al. CD4+ CD25+ Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS. One. 5, e15404 (2010).
52. Cheng, T. et al. Lysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation. J. Mol. Cell Biol. 6, 506-515 (2014).
53. Verrecchia, F., Mauviel, A. Transforming growth factor-beta and fibrosis. World J. Gastroenterol. 13, 3056-3062 (2007).
54. Hesse, M. et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544 (2001).